
Serbian scientists sell drug for autoimmune diseases and cancer for $1.9 billion
Sanofi, one of the world’s largest pharmaceutical companies, has acquired the Serbian biopharmaceutical company Dren Bio for $1.9 billion. Dren Bio is based in San Francisco and was founded by Serbian scientists. According to a joint statement from both …